BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24442345)

  • 1. Activation of Janus kinase/signal transducers and activators of transcription pathway involved in megakaryocyte proliferation induced by vanadium resembles some aspects of essential thrombocythemia.
    Gonzalez-Villalva A; PiƱon-Zarate G; Falcon-Rodriguez C; Lopez-Valdez N; Bizarro-Nevares P; Rojas-Lemus M; Rendon-Huerta E; Colin-Barenque L; Fortoul TI
    Toxicol Ind Health; 2016 May; 32(5):908-18. PubMed ID: 24442345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiation.
    Besancenot R; Roos-Weil D; Tonetti C; Abdelouahab H; Lacout C; Pasquier F; Willekens C; Rameau P; Lecluse Y; Micol JB; Constantinescu SN; Vainchenker W; Solary E; Giraudier S
    Blood; 2014 Sep; 124(13):2104-15. PubMed ID: 25143485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets.
    Glembotsky AC; Korin L; Lev PR; Chazarreta CD; Marta RF; Molinas FC; Heller PG
    Eur J Haematol; 2010 May; 84(5):398-405. PubMed ID: 20113333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humanized VB22B minibody for human Mpl stimulates human megakaryopoiesis but does not enhance platelet aggregation.
    Matsuki E; Miyakawa Y; Yamane A; Okamoto S
    Exp Hematol; 2011 Aug; 39(8):829-36. PubMed ID: 21605620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia.
    Pikman Y; Lee BH; Mercher T; McDowell E; Ebert BL; Gozo M; Cuker A; Wernig G; Moore S; Galinsky I; DeAngelo DJ; Clark JJ; Lee SJ; Golub TR; Wadleigh M; Gilliland DG; Levine RL
    PLoS Med; 2006 Jul; 3(7):e270. PubMed ID: 16834459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
    Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-Mannosylation of thrombopoietin receptor (c-Mpl) regulates thrombopoietin-dependent JAK-STAT signaling.
    Sasazawa Y; Sato N; Suzuki T; Dohmae N; Simizu S
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):262-8. PubMed ID: 26505790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
    Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
    Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lyn tyrosine kinase regulates thrombopoietin-induced proliferation of hematopoietic cell lines and primary megakaryocytic progenitors.
    Lannutti BJ; Drachman JG
    Blood; 2004 May; 103(10):3736-43. PubMed ID: 14726379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospho-STAT5 expression pattern with the MPL W515L mutation is similar to that seen in chronic myeloproliferative disorders with JAK2 V617F.
    Gibson SE; Schade AE; Szpurka H; Bak B; Maciejewski JP; Hsi ED
    Hum Pathol; 2008 Jul; 39(7):1111-4. PubMed ID: 18479730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel mutation in MPL (Y252H) results in increased thrombopoietin sensitivity in essential thrombocythemia.
    Lambert MP; Jiang J; Batra V; Wu C; Tong W
    Am J Hematol; 2012 May; 87(5):532-4. PubMed ID: 22389068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of megakaryocytopoiesis by thrombopoietin and stromal cells.
    Nagata Y; Nagahisa H; Nagasawa T; Todokoro K
    Leukemia; 1997 Apr; 11 Suppl 3():435-8. PubMed ID: 9209416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombopoietin signal transduction in purified murine megakaryocytes.
    Drachman JG; Sabath DF; Fox NE; Kaushansky K
    Blood; 1997 Jan; 89(2):483-92. PubMed ID: 9002950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icaritin Provokes Serum Thrombopoietin and Downregulates Thrombopoietin/MPL of the Bone Marrow in a Mouse Model of Immune Thrombocytopenia.
    Zhang K; Dai Z; Liu R; Tian F; Liu X; Sun Y; Zhao X; Pu X
    Mediators Inflamm; 2018; 2018():7235639. PubMed ID: 30224899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial essential thrombocythemia with spontaneous megakaryocyte colony formation and acquired JAK2 mutations.
    Higgs JR; Sadek I; Neumann PE; Ing VW; Renault NK; Berman JN; Greer WL
    Leukemia; 2008 Aug; 22(8):1551-6. PubMed ID: 18496561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospho-STAT5 and phospho-Akt expression in chronic myeloproliferative neoplasms.
    Grimwade LF; Happerfield L; Tristram C; McIntosh G; Rees M; Bench AJ; Boyd EM; Hall M; Quinn A; Piggott N; Scorer P; Scott MA; Erber WN
    Br J Haematol; 2009 Nov; 147(4):495-506. PubMed ID: 19747364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new feature of Mpl receptor: ligand-induced transforming activity in FRE rat fibroblasts.
    Challier C; Cocault L; Flon M; Pauchard M; Porteu F; Gisselbrecht S; Souyri M
    Oncogene; 2000 Apr; 19(16):2033-42. PubMed ID: 10803464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and maturation of megakaryocytes is regulated by Lnk/Sh2b3 adaptor protein through crosstalk between cytokine- and integrin-mediated signals.
    Takizawa H; Eto K; Yoshikawa A; Nakauchi H; Takatsu K; Takaki S
    Exp Hematol; 2008 Jul; 36(7):897-906. PubMed ID: 18456388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib.
    Shide K; Kameda T; Yamaji T; Sekine M; Inada N; Kamiunten A; Akizuki K; Nakamura K; Hidaka T; Kubuki Y; Shimoda H; Kitanaka A; Honda A; Sawaguchi A; Abe H; Miike T; Iwakiri H; Tahara Y; Sueta M; Hasuike S; Yamamoto S; Nagata K; Shimoda K
    Leukemia; 2017 May; 31(5):1136-1144. PubMed ID: 27807369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
    Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
    Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.